1-3 of 3
Alfredo Velena
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A178: Targeting the ATM-mediated DNA damage response pathway for cancer treatment

Scott Grindrod, Alfredo Velena, Mira Jung
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A178.
https://doi.org/10.1158/1535-7163.TARG-17-A178
Published: 01 January 2018
View article titled, Abstract A178: Targeting the ATM-mediated DNA damage response pathway for cancer treatment
Journal Articles

Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor

Yali Kong, Mira Jung, Kan Wang, Scott Grindrod, Alfredo Velena, Sung A. Lee, Sivanesan Dakshanamurthy, Yonghong Yang, Matthew Miessau, Chaoyi Zheng, Anatoly Dritschilo, Milton L. Brown
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (9): 1591–1599.
https://doi.org/10.1158/1535-7163.MCT-10-0779
Published: 07 September 2011
View article titled, Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor
Open the PDF for Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor in another window
Includes: Supplementary data
Journal Articles

Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors

Zacharoula Konsoula, Hong Cao, Alfredo Velena, Mira Jung
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (10): 2844–2851.
https://doi.org/10.1158/1535-7163.MCT-09-0629
Published: 12 October 2009
View article titled, Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors
Open the PDF for Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors in another window
Includes: Supplementary data